DOCSLIB.ORG

Deoxyribonucleic Acid Synthesis I. Effect of in Vivo Cyclophosphamide Treatment on the in Vitro Activity of the Deoxyribonucleic

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Deoxyribonucleic Acid Synthesis I. Effect of in Vivo Cyclophosphamide Treatment on the in Vitro Activity of the Deoxyribonucleic ICANCER RESEARCH 26 Part 1, 1466-1472,July 1966] Deoxyribonucleic Acid Synthesis I. Effect of in Vivo Cyclophosphamide Treatment on the in Vitro Activity of the Deoxyribonucleic Acid Synthetase System of Sensitive and Resistant Plasmacytomas1 ARTHUR J. TOMISEK, MARTHA BRUCE IRICK, AND PAULA WEDELES ALLAN Kettering'-Meyer Laboratory,2 Southern Research Institute, Birmingham, Alabama Summary term DNA-synthetase. In addition to this measurement of over-all DNA synthetase activity, we used the same experiments We have shown that the in vivo treatment of Fortner plasma- to determine the time course of radioactivity distribution among cytomas with Cyclophosphamide can lead to strong inhibitions of both deoxyribonucleic acid nucleotidyl transferase and thymi- the soluble components of the synthetase reaction mixtures. Our data show that the observed decreases in enzyme activity dylatc kinase activities in the soluble cell fractions. However, in are among the possible consequences of growth inhibition in the allowing only 2 hr for the inhibitor to act, the effect observed on tumor. the transferase was an unexplained stimulation rather than an inhibition. We have also provided some evidence that the inhibition of Materials and Methods growth precedes the inhibition of deoxyribonucleic acid nucleo ENZYME PREPARATION.Fortner hamster plasmacytoma tidyl transferase activity. ("sensitive") (3) and ite cyclophosphamide-resistant subline (12) were used for bilateral s.c. implantation into groups of 6-12 Introduction Golden Syrian hamsters, the animals in each experiment being uniform with respect to commercial subline, sex, and approxi Previous studies in this laboratory have shown that several mate age. On the 12th-14th postimplant day the animals were alkylating agents inhibited the in vivo synthesis of DNA by divided into 2 subgroups, to receive daily i.p. injections of Fortner hamster plasmacytomas and the in vitro synthesis of either saline or 10 mg/kg of Cyclophosphamide4 for either 1, 3, DNA by minces of these tumors (16). These studies have dealt or 5 injections. Hereafter these are referred to as "2-hr experi with the intact tumor-host system and with whole tumor cells. ments," "3-day experiments," and "5-day experiments." During As extensions of these studies, this and a related paper (17) deal the experimental period, animals were weighed daily and tumor with subcellular fractions from tumors which have been treated weights were estimated daily from caliper measurements. One in vivo with Cyclophosphamide. day after the final injection (except 2 hr for the 2-hr expérimente) For the present study the experiments of Mantsavinos and animals were stunned by carbon dioxide and killed by decapita Canellakis (10) and of Bollum (1) served as models for assaying tion. Pooled tumors were cooled, weighed, minced, passed for that portion of the DNA synthesis pathway which extends from the 4 substrates dTMP, dCMP, dAMP, and dGMP3 to through an extruder, and ground with 3 volumes of cold, buf fered (0.02 M Tris, pH 8) 0.25 M sucrose in a Potter-Elvejhem DNA. It is this multi-enzyme system to which we apply the homogenizer. After centrifugation at 100,000 X g for 1 hr, the clear aqueous supernatant was assayed for protein (9) and 1This investigation was supported by grants from the Alfred stored in a freezer till needed. In practice, the 4 enzymes of a set P. Sloan Foundation, the Charles F. Kettering Foundation, The were prepared in parallel and simultaneously assayed for syn John A. Hartford Foundation, Inc., and by the Cancer Chemo thetase activity within 1-7 days. Subsequent freezing-and- therapy National Service Center, National Cancer Institute, under the National Institutes of Health Contract No. SA-43-ph- thawings of these enzymes (for purposes other than the present 2433. A preliminary report was presented before the American report) showed that, within this age limit, the synthetase activity Association for Cancer Research, Chicago, Illinois, April 1964. 2Affiliated with the Sloan-Kettering Institute, New York, guauosine-5-triphosphate; GMP, guanosine-5'-phosphate; AMP, New York. adenosine-S'-phosphate; ATP, adenosine-S'-triphosphate; Tris, 3The abbreviations used are: dTMP, thymidine-5'-phosphate; tris(hydroxymethyl)aminomethane. (1TDP, thymidine-5'-diphosphate; dTTP, thymidine-5'-triphos- 42 - [Bis(/3-chloroethyl)amino] - 2H - 1,3,2 - oxazaphosphori- phate; dCMP, deoxycytidiiie-5'-phosphate; dCTP, deoxycytidine- nane-2-oxide. CCNSC 26271. Supplied by Cancer Chemotherapy 5-triphosphate; dAMP, deoxyadenosine-S'-phosphate; dADP, National Service Center. deoxyadenosine-5'-diphosphate; dATP, deoxyadenosine-5'-tri- Received for publication June 21, 1965; revised January 10, phosphate; dGMP, deo.\yguanosine-5'-phosphate; dGTP, deoxy- I960. 1400 CANCER RESEARCH VOL. 26 Downloaded from cancerres.aacrjournals.org on October 2, 2021. © 1966 American Association for Cancer Research. Deoxyribonucleic Acid Synthesis. I decrease was an average of 0.20 for each freezing and thawing cycle. However, the variability in this decrease was so great that we were unable to estimate the effect of enzyme storage per se. In this report, each pairing of treated and control enzymes and of sensitive and resistant enzymes is with other enzymes of the same set. ENZYMKASSAY.The enzyme assay reaction mixture (usually 1.25 ml total volume) contained the following ingredients (all given in /¿moles/mlof reaction mixture): sucrose, 222; Tris (pH 7.5) buffer, 8.8; ATP, 1.1; magnesium chloride, 1.1; potassium 3-phosphoglycerate, 5.0; potassium chloride, 40; dAMP, dGMP, and dCMP, 0.23 each; dTMP-14C, 0.046. The only other addi tions were enzyme fraction, to 4.62 mg protein/ml, and DXA primer, to 0.45 mg/ml. The primer used was high molecular weight calf thymus DNA (Worthington), heat-denatured shortly before the assay. When other radioactive substrates were substituted for dTMP-"C, the above protocol was preserved in always using the radioactive substrate at 0.20 the concentration of the other 3 substrates. In tests for possible RNA synthesis, the appropriate 40 80 120 160 200 240 4 ribonucleoside monophosphates were substituted. Reaction mixture minus the primer was preincubated for 10 Reaction time (min.) min at 37°Ctopermit conversion of the deoxyribonucleotidephos- CHART1. A set of curves for determination of deoxyribonucleic phates to their triphosphate forms. At the start of the incubation acid synthetase activities. The curves of this example are for and each 10 min thereafter, carefully measured 25-ß\aliquots control and 5-day cyclophosphamide-treated plasmacytomas of were removed and placed on paper discs for assay of DXA both the sensitive and cyclophosphamide-resistant sublincs. synthesis by the procedure of Bollum (1). Simultaneously with the removal of these aliquots, other aliquots (10 jul) were placed directly5 on paper for 1-dimensional chromatography. The which we can attach a dependable physical interpretation. In paper used was Whatman No. 1 except as noted. An isobutyric terms of absolute activity, the average incorporation of dTMP- 14Cinto insoluble DNA by sensitive control enzymes was 1.05 acid solvent (14) was found very effective when the radioactive substrate was dTMP. The common butanol-propionic acid mamóles/hr/ml of reaction mixture. But since these data are too solvent (13) was satisfactory when the radioactive substrate variable, we consider only enzyme activity ratios within each was AMP or dAMP, except that the respective di- and triphos- set of simultaneous assays. phates were not separated. An ammonium isobutyrate solvent6 For 2 sets of enzymes the reproducibility of the assay was gave passable separations when the radioactve substrate wasi checked by the use of alternative radioactive substrates (Table GMP, but it gave poor reparations when the radioactive sub 1). strate was dGMP. Phenol-water on Schleicher and Schnell No. The possibility of deoxyribonucleotide conversion to ribonu- 589 orange-label paper (13) was effective when the radioactive cleotides and subsequent synthesis of RNA was checked by using substrate was dCMP, except for the unimportant separation of the appropriate 4 ribonucleotides in place of the deoxyribonucleo- deoxycytidine from deoxyuridine and lesser degradation products. tides. When AMP-8-14C was the labeled substrate, "RNA" The separated reaction mixture components were cut from the synthesis did not begin till after 2 hr; and when GMP-8-14C was papergrams and assayed for 14Ccontent by liquid scintillation the labeled substrate, there appeared to be no RNA synthesis technics. at all. INTERPRETATIONOF THE CHROMATOGRAPHICANALYSES.Typi Results cal RF values obtained with the isobutyric acid solvent system were: 72, thymine; 64, thymidine; 54, unknown (maximum 5% NATURE OF THE SYNTHETASE ASSAY. Chart 1 shoWS a SCt of of total 14C after 2 hr); 32, dTMP; 27 unknown (maximum 1% curves obtained in a typical DNA-synthetase assay experiment. of total 14Cafter 2 hr) ; 17, dTDP; 10 and 5, dTTP. The initial, linear slopes of the curves are almost the only data to Chart 2 is an example of the data obtainable by the Chromato graphie analysis. From this and similar charts, the following 6 In a few experiments, the values for dTTP by this procedure conclusions are drawn: (a) At first, the kinase and phosphatase were found to average ^ less than for a procedure of placing the of dTMP compete in reducing the dTMP concentration to a aliquots in 80% ethanol before applying to the paper. But the low level. (6) After the dTMP level gets low enough, a thymidine direct application procedure resulted in much smoother time curves. The treated to control ratios were essentially the same kinase action can often be seen to cause an actual downturn in by both procedures. the thymidine curve, (c) The dTDP peak occurs well after the "Pabst Laboratories, Circular OR-18, April, 1961. Solvent IV. dTTP peak, which might possibly be taken to indicate that JULY I960 1407 Downloaded from cancerres.aacrjournals.org on October 2, 2021. © 1966 American Association for Cancer Research. Arthur J. Tomisek, Martha B.
Load more

Recommended publications
  • Nucleotide Metabolism Pathway: the Achilles' Heel for Bacterial Pathogens
    REVIEW ARTICLES Nucleotide metabolism pathway: the achilles’ heel for bacterial pathogens Sujata Kumari1,2,* and Prajna Tripathi1,3 1National Institute of Immunology, New Delhi 110 067, India 2Present address: Department of Zoology, Magadh Mahila College, Patna University, Patna 800 001, India 3Present address: Institute of Molecular Medicine, Jamia Hamdard, New Delhi 110 062, India de novo pathway, the nucleotides are synthesized from Pathogens exploit their host to extract nutrients for their survival. They occupy a diverse range of host simple precursor molecules. In the salvage pathway, the niches during infection which offer variable nutrients preformed nucleobases or nucleosides which are present accessibility. To cause a successful infection a patho- in the cell or transported from external environmental gen must be able to acquire these nutrients from the milieu to the cell are utilized to form nucleotides. host as well as be able to synthesize the nutrients on its own, if required. Nucleotides are the essential me- tabolite for a pathogen and also affect the pathophysi- Purine biosynthesis pathway ology of infection. This article focuses on the role of nucleotide metabolism of pathogens during infection The purine biosynthesis pathway is universally conserved in a host. Nucleotide metabolism and disease pathoge- in living organisms (Figure 1). As an example, we here nesis are closely related in various pathogens. Nucleo- present the pathway derived from well-studied Gram- tides, purines and pyrimidines, are biosynthesized by positive bacteria Lactococcus lactis. In the de novo the de novo and salvage pathways. Whether the patho- pathway the purine nucleotides are synthesized from sim- gen will employ the de novo or salvage pathway dur- ple molecules such as phosphoribosyl pyrophosphate ing infection is dependent on various factors, like (PRPP), amino acids, CO2 and NH3 by a series of enzy- availability of nucleotides, energy condition and pres- matic reactions.
    [Show full text]
  • Guanosine-Based Nucleotides, the Sons of a Lesser God in the Purinergic Signal Scenario of Excitable Tissues
    International Journal of Molecular Sciences Review Guanosine-Based Nucleotides, the Sons of a Lesser God in the Purinergic Signal Scenario of Excitable Tissues 1,2, 2,3, 1,2 1,2, Rosa Mancinelli y, Giorgio Fanò-Illic y, Tiziana Pietrangelo and Stefania Fulle * 1 Department of Neuroscience Imaging and Clinical Sciences, University “G. d’Annunzio” of Chieti-Pescara, 66100 Chieti, Italy; [email protected] (R.M.); [email protected] (T.P.) 2 Interuniversity Institute of Miology (IIM), 66100 Chieti, Italy; [email protected] 3 Libera Università di Alcatraz, Santa Cristina di Gubbio, 06024 Gubbio, Italy * Correspondence: [email protected] Both authors contributed equally to this work. y Received: 30 January 2020; Accepted: 25 February 2020; Published: 26 February 2020 Abstract: Purines are nitrogen compounds consisting mainly of a nitrogen base of adenine (ABP) or guanine (GBP) and their derivatives: nucleosides (nitrogen bases plus ribose) and nucleotides (nitrogen bases plus ribose and phosphate). These compounds are very common in nature, especially in a phosphorylated form. There is increasing evidence that purines are involved in the development of different organs such as the heart, skeletal muscle and brain. When brain development is complete, some purinergic mechanisms may be silenced, but may be reactivated in the adult brain/muscle, suggesting a role for purines in regeneration and self-repair. Thus, it is possible that guanosine-50-triphosphate (GTP) also acts as regulator during the adult phase. However, regarding GBP, no specific receptor has been cloned for GTP or its metabolites, although specific binding sites with distinct GTP affinity characteristics have been found in both muscle and neural cell lines.
    [Show full text]
  • T E C H N Ic a L R E F E R E N
    Abbreviations A E α alpha ED50 effective dose (for 50% of effect) Ab antibody EDTA ethylenediaminetetraacetic acid Ac-DEVD-AMC acetyl-Asp-Glu-Val-Asp-7-amino-4-methyl coumarin EGF epidermal growth factor (fluorogenic substrate for caspase-3/7) EGFR epidermal growth factor receptor Ac-DEVD-CHO acetyl-Asp-Glu-Val-Asp-1-aldehyde EGTA ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (reversible aldehyde inhibitor of caspase-3/7) ELISA enzyme-linked immunosorbent assay Ac-DEVD-pNA acetyl-Asp-Glu-Val-Asp-pNA (colorimetric substrate for caspase-3/7) em emission Ac-YVAD-AMC acetyl-Tyr-Val-Ala-Asp-amino methyl coumarin ERK1, 2 extracellular signal-regulated protein kinase 1, 2 (fluorogenic substrate for caspase-1) EtBr ethidium bromide Ac-YVAD-CHO acetyl-Tyr-Val-Ala-Asp-1-aldehyde EtOH ethanol (reversible aldehyde inhibitor of caspase-1) ex excitation ADP adenosine diphosphate Ad-2 adenovirus-2 F AKAP A-kinase anchoring protein FAB/MS fast atomic bombardment mass spectrometry a.m.u. atomic mass unit FACS fluorescence-activated cell sorting AMC 7-amino-4-methyl coumarin FGF fibroblast growth factor amol attomole (10–18 mole) FITC fluorescein isothiocyanate AMP adenosine monophosphate FITC-VAD-FMK FITC-carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]- AMV avian myeloblastosis virus fluoromethylketone (fluorescent marker for caspase activity) AP alkaline phosphatase FL fluorescein –15 AP1, 2 activator protein 1, 2 fmol femtomole (10 mole) APC film automatic processor-compatible film G ARE AU-rich element γ gamma ATP adenosine triphosphate
    [Show full text]
  • Arthur Kornberg
    A RTHUR K O R N B E R G The biologic synthesis of deoxyribonucleic acid Nobel Lecture, December 11, 1959 The knowledge drawn in recent years from studies of bacterial transforma- tion 1 and viral infection of bacterial cells 2,3 combined with other evidences, has just about convinced most of us that deoxyribonucleic acid (DNA) is the genetic substance. We shall assume then that it is DNA which not only directs the synthesis of the proteins and the development of the cell but that it must also be the substance which is copied so as to provide for a similar development of the progeny of that cell for many generations. DNA, like a tape recording, carries a message in which there are specific instructions for a job to be done. Also like a tape recording, exact copies can be made from it so that this information can be used again and elsewhere in time and space. Are these two functions, the expression of the code (protein synthesis) and the copying of the code (preservation of the race) closely integrated or are they separable? What we have learned from our studies over the past five years and what I shall present is that the replication of DNA can be exam- ined and at least partially understood at the enzymatic level even though the secret of how DNA directs protein synthesis is still locked in the cell. First I should like to review very briefly some aspects of DNA structure which are essential for this discussion. Analysis of the composition of samples of DNA from a great variety of sources and by many investigators4 revealed the remarkable fact that the purine content always equals the pyrimidine content.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,794,936 B1 Benner Et Al
    US007794936B1 (12) United States Patent (10) Patent No.: US 7,794,936 B1 Benner et al. (45) Date of Patent: Sep. 14, 2010 (54) USING THYMIDINE ANALOGS TO IMPROVE Michiko Kimoto, Rie Kawai, Tsuneo Mitsui, Shigeyuki Yokoyama, REPLICATION IN AN EXPANDED GENETIC Ichiro Hirao An unnatural base pair system for efficient PCR ampli ALPHABET fication and functionalization of DNA molecules Nucleic Acids Research, 2009, vol. 37, No. 2 e14. (76) Inventors: Steven Albert Benner, 1501 NW. 68" Chen, F., Gaucher, E. A., Leal, N. A., Hutter, D., Havemann, S.A., Govindarajan, S., Ortlund, E. A., Benner, S.A. (2010) Reconstructed Ter, Gainesville, FL (US) 32605-4147: evolutionary adaptive paths give polymerases accepting reversible Albert Michael Sismour, 85 Hancock terminators for sequencing and SNP detection. Proc. Natl. Acad. Sci. St., Apt. 7, Cambridge, MA (US) 02139 USA 107, 5, 1948-1953. (*) Notice: Subject to any disclaimer, the term of this * cited by examiner patent is extended or adjusted under 35 U.S.C. 154(b) by 534 days. Primary Examiner Heather Calamita (21) Appl. No.: 11/541.295 (57) ABSTRACT (22) Filed: Sep. 29, 2006 This invention relates to nucleoside, nucleotide, and oligo (51) Int. Cl. nucleotide analogs that incorporate non-standard nucleobase CI2O I/68 (2006.01) analogs, those that present a pattern of hydrogen bonds to a paired nucleobase analog in a complementary strand that is (52) U.S. Cl. ........................ 435/6:536/22.1536/24.33 different from the pattern presented by adenine, guanine, (58) Field of Classification Search ....................... None cytosine, and thymine. Most specifically, this invention dis See application file for complete search history.
    [Show full text]
  • A New Base Pair with an Alternative Hydrogen Bonding Pattern Zunyi Yang, Daniel Hutter, Pinpin Sheng, A
    Published online 29 October 2006 Nucleic Acids Research, 2006, Vol. 34, No. 21 6095–6101 doi:10.1093/nar/gkl633 Artificially expanded genetic information system: a new base pair with an alternative hydrogen bonding pattern Zunyi Yang, Daniel Hutter, Pinpin Sheng, A. Michael Sismour and Steven A. Benner* Foundation for Applied Molecular Evolution, 1115 NW 4th Street, Gainesville, FL 32601, USA Received June 14, 2006; Revised August 9, 2006; Accepted August 12, 2006 ABSTRACT have sought to change hydrogen-bonding patterns and to control the outcome with sulfur and/or steric interactions. To support efforts to develop a ‘synthetic biology’ Kool and his group have sought to dispense with hydrogen based on an artificially expanded genetic informa- bonding entirely (9,10), as have Romesberg, Schultz and tion system (AEGIS), we have developed a route their coworkers (11,12) using hydrophobic interactions. to two components of a non-standard nucleobase In the opposite direction, Minakawa et al. have sought to pair, the pyrimidine analog 6-amino-5-nitro-3- increase the number of interpair hydrogen bonds (13). (10-b-D-20-deoxyribofuranosyl)-2(1H)-pyridone (dZ) Despite the success of this work, alternative nucleic acid- and its Watson–Crick complement, the purine like systems that deviate less drastically from the standard analog 2-amino-8-(10-b-D-20-deoxyribofuranosyl)- design have had, to date, the technological success and sup- imidazo[1,2-a]-1,3,5-triazin-4(8H)-one (dP). These ported best the emerging field of synthetic biology (14). If implement the pyDDA:puAAD hydrogen bonding nitrogen and oxygen are used as the only heteroatoms, six different hydrogen-bonding patterns can be directly placed pattern (where ‘py’ indicates a pyrimidine analog within the standard Watson–Crick geometry.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,673,576 B1 Usuda Et Al
    USOO6673576B1 (12) United States Patent (10) Patent No.: US 6,673,576 B1 USuda et al. (45) Date of Patent: Jan. 6, 2004 (54) PROCESS FOR PRODUCING NUCLEIC OTHER PUBLICATIONS ACDS K. W. Harlow, et al., Journal of Bacteriology, vol. 177, No. (75) Inventors: Yoshihiro Usuda, Kawasaki (JP); 8, pp. 2236 to 2240, “Cloning and Characterization of the Hisashi Kawasaki, Kawasaki (JP); gsk Gene Encoding Guanosine Kinase of Escherichia coli, Megumi Shimaoka, Kawasaki (JP); Apr. 1995. Takashi Utagawa, Kawasaki (JP) H. Mori, et al., Journal of Bacteriology, vol. 177, No. 17, pp. 4921 to 4926, “Cloning of a Guanosine-Inosine Kinase (73) Assignee: Ajinomoto Co., Inc., Tokyo (JP) Gene of Escherichia coli and Characterization of the Puri fied Gene Product”, Sep. 1995. * Y NotOtice: Subjubject to anyy disclaimer,disclai theh term off thisthi Y. Usuda, et al., Journal of Bacteriology, vol. 179, No. 22, patent is extended or adjusted under 35 pp. 6959 to 6964, “Molecular Cloning and Transcriptional U.S.C. 154(b) by 0 days. Analysis of a Guanosine Kinase Gene of Brevibacterium (21) Appl. No.: 08/913,816 Acetylicum ATCC 953”, Nov. 1997. Y. USuda, et al., Biochimica et Biophysica Acta 1341, pp. (22) PCT Filed: Mar. 22, 1996 200 to 206, "Characterization of Guanosine Kinase from (86) PCT No.: PCT/JP96/00761 Brevibacterium Acetylicum ATCC 953", 1997. H. Shirae, et al., BioSciences Information Service, 1 page, S371 (c)(1), XP-002147617, “Purification and Properties of Purine (2), (4) Date: May 13, 1998 Nucleoside Phosphorylase from Brevibacterium-Acetyli (87) PCT Pub. No.: WO96/30501 cum ATCC 954, 1991.
    [Show full text]
  • Original Article Effect of Nucleoside and Nucleotide Reverse Transcriptase Inhibitors of HIV on Endogenous Nucleotide Pools
    Antiviral Therapy 13:789–797 Original article Effect of nucleoside and nucleotide reverse transcriptase inhibitors of HIV on endogenous nucleotide pools Jennifer E Vela1, Michael D Miller2, Gerald R Rhodes1 and Adrian S Ray1* 1Department of Preclinical Drug Metabolism, Gilead Sciences, Inc., Foster City, CA, USA 2Department of Clinical Virology, Gilead Sciences, Inc., Foster City, CA, USA *Corresponding author: E-mail: [email protected] Background: Alterations in endogenous nucleotide pools Incubation of 10 µM AZT, either alone or in combination as a result of HIV therapy with nucleoside and nucleotide with other N(t)RTIs, increased 2′-deoxyadenosine triphos- reverse transcriptase inhibitors (N[t]RTIs) is a proposed phate, 2′-deoxyguanosine triphosphate and thymidine mechanism for therapy-related adverse events and drug triphosphate levels by up to 1.44-fold the concentrations interactions resulting in treatment failure. In vitro stud- observed in untreated cells. At higher than pharmaco- ies were performed in order to understand the effect of logical concentrations of AZT, evidence for inhibition of N(t)RTIs on endogenous nucleotide pools. 2′-deoxycytidylate deaminase and enzymes involved in the Methods: The T-cell line CEM-CCRF was treated with control salvage of thymidine was also observed. Phosphorylated antimetabolites or the N(t)RTIs abacavir, didanosine, lami- metabolites of TFV are known to inhibit purine nucleoside vudine, tenofovir (TFV) and zidovudine (AZT), either alone phosphorylase (PNP). However, in contrast to a potent PNP or in combination. The levels of natural 2′-deoxynucleoside inhibitor, TFV was unable to alter intracellular dNTP pools triphosphates (dNTP) and ribonucleoside triphophosphates upon addition of exogenous 2′-deoxyguanosine.
    [Show full text]
  • Chimp Report
    ChImp Report Chances and Implications of an Expanded Genetic Code iGEM Bielefeld-CeBiTec 2017 Table of Contents Abstract ...................................................................................................................................... 3 Motivation .................................................................................................................................. 4 Background ................................................................................................................................ 6 Historical Background ............................................................................................................ 6 Legal Situation in Germany ................................................................................................... 8 Current State of Research of expanded or synthetic DNA ..................................................... 9 Chances and Implications of an Expanded Genetic Code ........................................................ 12 The Scientific Perspective .................................................................................................... 12 The Philosophical and Ethical Perspective .......................................................................... 16 The Religious Perspective .................................................................................................... 21 The Public´s Perspective ...................................................................................................... 26 Results .....................................................................................................................................
    [Show full text]
  • Different Modes of Transport for 3H-Thymidine, 3H-FLT, and 3H-FMAU in Proliferating and Nonproliferating Human Tumor Cells
    Different Modes of Transport for 3H-Thymidine, 3H-FLT, and 3H-FMAU in Proliferating and Nonproliferating Human Tumor Cells David A. Plotnik1, Lindsay E. Emerick1, Kenneth A. Krohn2, Jashvant D. Unadkat3, and Jeffrey L. Schwartz1 1Department of Radiation Oncology, University of Washington, Seattle, Washington; 2Department of Radiology, University of Washington, Seattle, Washington; and 3Department of Pharmaceutics, University of Washington, Seattle, Washington The basis for the use of nucleoside tracers in PET is that activity of the cell-growth–dependent enzyme thymidine kinase 1 is the PET provides a noninvasive approach to measuring tumor rate-limiting factor driving tracer retention in tumors. Recent growth and response to therapy (1,2). Labeled thymidine and publications suggest that nucleoside transporters might influ- 3 9 9 ence uptake and thereby affect the tracer signal in vivo. Under- thymidine analogs such as [methyl- H]-3 -deoxy-3 -fluoro- 3 3 standing transport mechanisms for different nucleoside PET thymidine ( H-FLT) and H-1-(2-deoxy-2-fluoro-b-D-arabi- tracers is important for evaluating clinical results. This study nofuranosyl)-5-methyluracil (3H-FMAU) are being studied examined the relative role of different nucleoside transport for their use as PET-based proliferation tracers (3–7). The mechanisms in uptake and retention of [methyl-3H]-39-deoxy- primary factor driving nucleoside uptake and retention in 9 3 3 3 3 -fluorothymidine ( H-FLT), [methyl- H]-thymidine ( H-thymi- tumors is assumed to be thymidine kinase 1 (TK1) (a cyto- dine), and 3H-1-(2-deoxy-2-fluoro-b-D-arabinofuranosyl)-5- methyluracil (3H-FMAU). Methods: Transport of 3H-FLT, 3H- solic enzyme).
    [Show full text]
  • Cytotoxic and Biochemical Effects of Thymidine and 3-Deazauridine on Human Tumor Cells1
    [CANCER RESEARCH 44, 2534-2539. June 1984] Cytotoxic and Biochemical Effects of Thymidine and 3-Deazauridine on Human Tumor Cells1 Arnold Lockshin, John T. Mendoza, Beppino C. Giovanella,2 and John S. Stehlin, Jr. St. Joseph Hospital Laboratory for Cancer Research, Houston, Texas 77002 ABSTRACT cells, thymidine-resistant human malignant B-cells have much lower ratios of these activities (6, 19). The cause of thymidine- Cytotoxicity and perturbations of the deoxyribonucleoside tri- induced inhibition of DNA synthesis in mammalian cells has been phosphate pools caused by thymidine were studied in thymidine- ascribed to depletion of the intracellular dCTP pool brought about sensitive and -resistant human tumor cells. Incubation with 1 mw by allosteric effects of dTTP on ribonucleotide reducíase(2, 33, thymidine reduced cell viability by more than 90% in the three 36). Other investigators have concluded that the decrease in the sensitive cell lines (two melanomas and one adrenal carcinoma) dCTP pool is too small to account for growth inhibition of L1210 and reduced the growth rate without decreasing the viability of murine leukemia cells (14) and that high levels of dTTP (and/or resistant LO melanoma cells. Thymidine (1 HIM)greatly increased other dNTPs3) interact with a regulatory protein for DNA polym- the ratio of the deoxythymidine 5'-triphosphate to deoxycytidine 5'-triphosphate pools in the sensitive cells compared to LO cells erase (37). Yet another interpretation is that imbalance of the pyrimidine dNTP pools brought about by supranormal levels of and also caused larger relative increases in the pool sizes of deoxyguanosine 5'-triphosphate and deoxyadenosine 5'-tri- exogenous thymidine causes misincorporation of bases into DNA, which leads to mutagenicity and cytotoxicity (4).
    [Show full text]
  • Mass Spectrometry – a Powerful Tool for Metabolomics Sandy Nargund Manager, MS & Chromato Shimadzu [Asia-Pacific] Pte Ltd
    Mass Spectrometry – A Powerful tool for metabolomics Sandy Nargund Manager, MS & Chromato Shimadzu [Asia-Pacific] Pte Ltd 1 2 Biomarkers Identification and Validation 3 Mass Spectrometry –For Metabolomics GCMS-QP2010 Ultra GCMS-TQ 8040 LCMS-8060 Nexera UC- Online SFE/SFC iDPlus-Performance Bacterial Identification MALDI -7090 High Resolution TOF iMScope-Trio –Mass imaging 4 t Triple Quadrupole MS/MS Product ion scan t MRM- Multi Reaction Monitoring SIM (single analysis) MRM (MS/MS analysis) 50000 10 ppb 7500 10 ppb 40000 5000 30000 20000 2500 10000 0 0 1.0 1.5 2.0 2.5 min 1.0 1.5 2.0 2.5 min Eliminates background for High sensitivity but high trace-level quantitation with background high S/N GCMS- Gold Standard for Metabolomics 7 Metabolomics Research Using GC-MS/MS Metabolomics Research Discovery phase Validation phase Scan measurement MRM measurement MRM measurement (GC-MS/MS) (non-targeted analysis) (wide target analysis) (target analysis) Detect marker candidates Quantitate marker candidates and identify compounds with higher accuracy Accurate quantitation GC/MS Metabolite Database Ready to use method for quick start your Research 1. Method files Registered Measurement Number Derivatives Compounds Mode Registered 2. Library (scan) Organic acids, fatty Scan 428 3. Smart MRM database acids, amino acids, TMS sugars, etc. MRM 193 (automatic method creation tool) Scan 50 4. Instruction manuals Fatty acids Methylation MRM 50 Amino acids EZ:faastTM Scan 33 Easy Work Flow AART function for Automatic Adjustment of Retention Indices with just one injection Select components for measurement from the database. Smart MRM database Method is created Automatically Start acquisition.
    [Show full text]